Brief: Scinai Reports Full-Year 2025 Results, With Cdmo Revenues Doubling And Strategic Expansion Through Recipharm Collaboration
01/04/2026 13:03
April 1 (Reuters) - Scinai Immunotherapeutics Ltd 2F5y.F: SCINAI REPORTS FULL-YEAR 2025 RESULTS, WITH CDMO REVENUES DOUBLING AND STRATEGIC EXPANSION THROUGH RECIPHARM COLLABORATION Source text: ID:nPn5XXk8a Further company coverage: [2F5y.F] ((Reuters.Briefs@thomsonreuters.com;))